Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Historique:
received: 30 09 2018
revised: 05 03 2019
accepted: 23 03 2019
pubmed: 16 7 2019
medline: 26 11 2019
entrez: 15 7 2019
Statut: ppublish

Résumé

After living donor liver transplantation, we encounter cases with massive ascites, which is difficult to manage. We analyzed the risk factors for massive ascites after living donor liver transplantation. The subjects were 100 adult recipients who underwent living donor liver transplantation at Kyoto University Hospital from 2013 to 2017. We retrospectively assessed patient, graft, operative factors, and percent fluid overload, which were defined as [(weight on the day - preoperative weight)/preoperative weight] × 100%. We defined the massive ascites group as having a14-day average ascites ≥ 2500 mL and the mild ascites group as having a 14-day average ascites < 2500 mL. Forty-seven patients were included in the massive group, and 53 patients were included in the mild group. There was no difference in short- and long-term survival. In multivariate analysis, the presence of preoperative ascites (P = .0008), 14-day average percent fluid overload ≥ 14.5% (P = .0095), graft-to-recipient weight ratio < 0.86 (P = .0253), and donors' age ≥ 47 years (P = .0466) were identified as independent risk factors for massive ascites after living donor liver transplantation. A liver graft with a small graft-to-recipient weight ratio or from an elderly donor, which may indicate poor graft quality, presence of preoperative ascites, and postoperative fluid overload were associated with massive ascites after living donor liver transplantation.

Identifiants

pubmed: 31301855
pii: S0041-1345(18)31287-9
doi: 10.1016/j.transproceed.2019.03.038
pii:
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1779-1784

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Kentaro Iwaki (K)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Shintaro Yagi (S)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan. Electronic address: shintaro@kuhp.kyoto-u.ac.jp.

Satoshi Morita (S)

Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yuhei Hamaguchi (Y)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Yuki Masano (Y)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Gen Yamamoto (G)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Eri Ogawa (E)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Kazuyuki Nagai (K)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Naoko Kamo (N)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Koichiro Hata (K)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Kojiro Taura (K)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Hideaki Okajima (H)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Toshimi Kaido (T)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Shinji Uemoto (S)

Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH